🔎 Trials Near Me

Akèy › Kansè poumon › Kalifòni › Daly City

Etid klinik pou Kansè poumon nan Daly City, CA

5 etid pou Kansè poumon ap chèche patisipan nan sit nan ak bò kote Daly City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Ap rekriteFaz 3
  • Kaiser Permanente-South San Francisco, South San Francisco · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT04267848

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Ap rekriteFaz 3
  • Kaiser Permanente-South San Francisco, South San Francisco · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT04181060

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Ap rekriteFaz 3
  • Kaiser Permanente-South San Francisco, South San Francisco · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06498635

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Ap rekriteFaz 2
  • Kaiser Permanente-South San Francisco, South San Francisco · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jun 3, 2026 · NCT05642572

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Ap rekriteFaz 2/3
  • Kaiser Permanente-South San Francisco, South San Francisco · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou May 5, 2026 · NCT06616584

Etid Kansè poumon nan lòt vil

Lòt etid nan Daly City

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.